Suppr超能文献

罕见的混合性甲状腺癌:两例报告

Rare Mixed Thyroid Carcinomas: A Report of Two Cases.

作者信息

Subramanian Nitya, Agarwal Sangeet Kumar, Agarwal Alok, Gupta Pallav

机构信息

Department of ENT, Sir Ganga Ram Hospital, New Delhi-110060.

Department of Pathology, Sir Ganga Ram Hospital, New Delhi-110060.

出版信息

Iran J Otorhinolaryngol. 2022 Jan;34(120):55-57. doi: 10.22038/IJORL.2021.48526.2614.

Abstract

INTRODUCTION

Thyroid cancers constitute 0.5%- 1% of all cancers of which differentiated cancers are most common. Mixed thyroid carcinomas are rare entities comprising only 0.5% of thyroid cancers. These tumours pose challenges in diagnosis by fine needle aspiration cytology.

CASE REPORT

Here, we present two rare cases of these mixed thyroid carcinomas. The first is that of a 21 year old female diagnosed with medullary thyroid carcinoma by the method of fine needle aspiration cytology (FNAC). She underwent definitive surgical treatment. Final histopathology revealed diagnosis of a nodular tumour with mixed features predominantly medullary carcinoma with areas of follicular carcinoma, confirmed on immunohistochemistry. Second report is that of a 45-year- old female diagnosed as medullary thyroid carcinoma on fine needle aspiration cytology (FNAC). Definitive surgical treatment was performed. Histopathology showed a mixed tumour with medullary and papillary components as confirmed through the process of immunohistochemistry.

CONCLUSIONS

The knowledge of these rare carcinomas is important in avoiding a dilemma in management of this condition. Detection of these mixed tumours is difficult by FNAC. The definitive treatment essentially requires recognition of medullary component. We re-emphasize the importance of immune-histochemistry in arriving at an accurate diagnosis.

摘要

引言

甲状腺癌占所有癌症的0.5%-1%,其中分化型癌症最为常见。混合性甲状腺癌是罕见的实体,仅占甲状腺癌的0.5%。这些肿瘤在细针穿刺细胞学诊断中具有挑战性。

病例报告

在此,我们呈现两例罕见的混合性甲状腺癌病例。第一例是一名21岁女性,通过细针穿刺细胞学检查(FNAC)诊断为甲状腺髓样癌。她接受了确定性手术治疗。最终组织病理学显示为一个具有混合特征的结节性肿瘤,主要为髓样癌,伴有滤泡癌区域,免疫组化证实。第二例报告是一名45岁女性,细针穿刺细胞学检查(FNAC)诊断为甲状腺髓样癌。进行了确定性手术治疗。组织病理学显示为一个具有髓样和乳头状成分的混合性肿瘤,免疫组化过程证实。

结论

了解这些罕见的癌症对于避免这种疾病管理中的困境很重要。通过FNAC检测这些混合性肿瘤很困难。确定性治疗基本上需要识别髓样成分。我们再次强调免疫组化在做出准确诊断中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb1/8801016/f72bbc1b4a79/ijo-34-55-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验